8:30am

Conference registration with arrival tea & coffee

9:00am

Welcome and Official opening

Morris S Berrie, Co-Founder/Chairman, TTS Global Initiative

Glenn Cross, CEO, AusBiotech

Dean Moss, CEO, UniQuest

9:15am

Keynote 1:  The trials and tribulations of running a successful TTO. What’s the end game? Can the launch of the Apollo fund change the game?

Cengiz Tarhan, Managing Director, UCLB 

10:15am

Session 1: Changes in Tech Transfer – the organization and the personnel

11:00am

Morning Tea 

11:30am

Briefing 1: Better understanding Discounted Cash Flow and Net Present Value

Patrik Frei, CEO, Venture Valuations, Switzerland 

12:00pm

Session 2: Big Pharma – what is required to work with Big Pharma when fundamentally they are based “overseas’? How diligently do you need to manage the relationship?

12:45pm

Lunch 

2:00pm

Session 3: Drug discovery in academia. Accelerating and curtailing programmes; understanding the value proposition from an Early stage commercialisation perspective

2:45pm

Industry Box

3:30pm

Afternoon Tea 

4:00pm

Briefing 2: Analysis. A dirty word in biotech 

4:15pm

Investor panel

Michael Molinari, Investment Manager, Brandon Capital 

Peter Devine, CEO, Uniseed Management 

5:00pm

Networking reception

Supported by:

6:30pm

TTS Australia Dinner

8:30am Conference registration with arrival tea & coffee
9:00am

Keynote 2: Interview with…

David Blake, Co-Founder, Bioshares 

10:00am

Session 5: Medtech panel

Malcolm Hebblewhite, VP Business Development, Planet Innovation 

10:40am

Briefing 3: MTPConnect update

Alfredo Martinez-Coll, General Manager, Stakeholder Engagement

11:00am

Session 6: Bionomics / Merck – case study

Phil Kearny, Director, Merck

11:30am

Morning Tea

12:00pm Session 7: IP session
12:30pm Keynote 3
1:30pm TTS Australia closing
1:45pm Closing networking lunch

Tweets by @AusBiotech

Major Partner